Profile data is unavailable for this security.
About the company
Arvee Laboratories (India) Limited is an India-based company engaged in manufacturing of specialized chemicals. The Company's product categories include polymer modifiers, contrast media intermediates and drug intermediates. Its polymer modifiers products include Dimethyl 5-Sodiosulfoisophthalate, 5-Sulfoisophthalic Acid Mono Sodium Salt, 5-Sulfoisophthalic Acid Mono Lithium Salt and 5-Sodiosulfo-Bis-(B-Hydroxyethyl)-Isophthalate. The Company's contrast media intermediates products include 5-Nitroisophthalic acid, Dimethyl 5-Nitroisophthalate, Monomethyl 5-Nitroisophthalate, 5-Hydroxyisophthalic acid, 5-Aminoisophthalic acid, Dimethyl 5-Aminoisophthalate, and 3,5-Diamino Benzoic Acid. Its drug intermediates products include 2-Acetyl Thiophene, Thiophene-2-Carboxaldehyde, 4-Amino Pyridine and 2-Chloro-5-Nitrobenzoic Acid.
- Revenue in INR (TTM)303.45m
- Net income in INR10.52m
- Incorporated2012
- Employees67.00
- LocationArvee Laboratories (India) Ltd403, Entice Building,, Opposite JayantilBRTS Bus Stop,, Iskcon Bopal Road, AmblIAHMEDABAD 380058IndiaIND
- Phone+91 2 717430479
- Fax+91 7 926742600
- Websitehttp://arveelabs.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
IVP Ltd | 5.46bn | 122.80m | 1.69bn | 202.00 | 13.80 | 1.31 | 9.51 | 0.3103 | 11.89 | 11.89 | 528.79 | 125.48 | 1.53 | 5.29 | 2.88 | -- | 3.44 | 3.40 | 9.60 | 11.37 | 18.98 | 16.62 | 2.25 | 2.36 | 0.9069 | 2.57 | 0.408 | 9.60 | -17.38 | 11.29 | -56.17 | 29.44 | -33.78 | 0.00 |
Vital Chemtech Ltd | 1.06bn | 38.23m | 1.87bn | 46.00 | 48.98 | 2.12 | 30.72 | 1.76 | 1.59 | 1.59 | 44.08 | 36.69 | 0.9289 | 7.48 | 2.74 | 23,020,740.00 | 3.35 | -- | 5.19 | -- | 18.90 | -- | 3.61 | -- | 3.22 | 4.25 | 0.2025 | -- | 102.63 | -- | 1.94 | -- | -- | -- |
Aksharchem (India) Ltd | 3.02bn | -186.77m | 2.05bn | 169.00 | -- | 0.792 | -- | 0.6797 | -23.26 | -23.26 | 377.04 | 322.65 | 0.8101 | 2.92 | 7.23 | -- | -5.01 | 1.36 | -6.11 | 1.64 | 39.96 | 34.01 | -6.18 | 1.61 | 0.7974 | -3.30 | 0.1666 | 28.33 | -9.75 | -1.33 | -1,882.52 | -- | -19.80 | -32.24 |
Arvee Laboratories (India) Ltd | 303.45m | 10.52m | 2.13bn | 67.00 | 201.09 | 7.31 | 83.42 | 7.01 | 0.96 | 0.96 | 27.89 | 26.42 | 0.7857 | 2.70 | 3.30 | -- | 2.72 | 6.66 | 3.44 | 10.12 | 51.24 | 38.26 | 3.47 | 5.63 | 2.23 | 6.00 | 0.0332 | -- | -50.54 | -11.18 | -74.46 | -14.21 | 11.47 | -- |
Paragon Fine & Speciality Chemical Ltd | -100.00bn | -100.00bn | 2.43bn | -- | -- | 9.35 | -- | -- | -- | -- | -- | 13.27 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 1.14 | -- | 0.5107 | -- | 23.47 | -- | 120.30 | -- | -- | -- |
Hindcon Chemicals Ltd | 645.09m | 61.81m | 2.55bn | -- | 34.28 | 3.83 | 38.75 | 3.96 | 1.45 | 1.45 | 15.60 | 13.02 | 1.14 | 19.13 | 2.66 | -- | 11.01 | 9.40 | 13.41 | 11.71 | 28.06 | 22.34 | 9.66 | 7.29 | 4.77 | 89.19 | 0.00 | -- | -24.63 | 7.70 | 43.10 | 16.99 | 137.12 | 10.76 |